153 related articles for article (PubMed ID: 1875222)
1. Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
Rosen PP; Groshen S; Kinne DW
J Clin Oncol; 1991 Sep; 9(9):1650-61. PubMed ID: 1875222
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.
Rosen PP; Groshen S; Kinne DW; Norton L
J Clin Oncol; 1993 Nov; 11(11):2090-100. PubMed ID: 8229123
[TBL] [Abstract][Full Text] [Related]
3. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Rosen PR; Groshen S; Saigo PE; Kinne DW; Hellman S
J Clin Oncol; 1989 Mar; 7(3):355-66. PubMed ID: 2918331
[TBL] [Abstract][Full Text] [Related]
4. Nonmammary malignant neoplasms in patients with stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. A long-term follow-up study.
Rosen PP; Groshen S; Kinne DW; Hellman S
Am J Clin Oncol; 1989 Oct; 12(5):369-74. PubMed ID: 2801596
[TBL] [Abstract][Full Text] [Related]
5. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
[TBL] [Abstract][Full Text] [Related]
6. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
[TBL] [Abstract][Full Text] [Related]
7. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up.
Rosen PP; Groshen S; Kinne DW; Hellman S
Surgery; 1989 Nov; 106(5):904-10. PubMed ID: 2814824
[TBL] [Abstract][Full Text] [Related]
8. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
[TBL] [Abstract][Full Text] [Related]
9. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
12. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
13. Conservation therapy for invasive lobular carcinoma of the breast.
Poen JC; Tran L; Juillard G; Selch MT; Giuliano A; Silverstein M; Fingerhut A; Lewinsky B; Parker RG
Cancer; 1992 Jun; 69(11):2789-95. PubMed ID: 1571910
[TBL] [Abstract][Full Text] [Related]
14. Outcome of small invasive breast cancer with no axillary lymph node involvement.
Sánchez-Muñoz A; Pérez-Ruiz E; Jurado JM; Ribelles N; Márquez A; Miramón J; Maíz M; Pajares B; Gallego E; Scholtz V; Jiménez B; Soler C; Molina M; García-Ríos I; Alba E
Breast J; 2011; 17(1):32-8. PubMed ID: 21129091
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
16. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
17. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
[TBL] [Abstract][Full Text] [Related]
18. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
19. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
20. Late mortality from pT1N0M0 breast carcinoma.
Joensuu H; Pylkkänen L; Toikkanen S
Cancer; 1999 May; 85(10):2183-9. PubMed ID: 10326696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]